Phase 3 N=621 Randomized Single-blind Prevention

Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Volunteers

Surgery

Bottom Line

View on ClinicalTrials.gov: NCT02526667 ↗

Enrolled (actual)

621

Serious AEs

0.0%

Results posted

Sep 2020

Primary outcome: Primary: Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin — 78; 84; 54; 56 Percent of sites

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Chlorhexidine gluconate (Drug); DynaHex-2 (Drug); Vehicle (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Medline Industries
Primary completion: Dec 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin	78; 84; 54; 56; 72; 73	—

Summary

Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.

Eligibility Criteria

Inclusion Criteria

Males or Females
18 years of age or older
Signed informed consent
Good Health
Six inches of abdomen and groin areas without tattoos, or skin disorders

Exclusion Criteria

Dermatological Conditions
Sensitivity to latex
Sensitivity to CHG

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02526667). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.